Mariano Provencio, MD, PhD, on NSCLC: Results From the NADIM and NORA Trials

Posted: Wednesday, October 4, 2017

Mariano Provencio, MD, PhD, of the Hospital Universitario Puerta de Hierro, discusses study findings on neoadjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non–small cell lung cancer; and concurrent chemoradiotherapy with cisplatin plus metronomic oral vinorelbine for unresectable, locally advanced disease.